Global Pirfenidone Market

Market Size in USD Billion

CAGR : 17.60%

USD 1.14

2025

USD 4.17

2033

Forecast Period	2025 - 2033
Market Size (Base Year)	USD 1.14 Billion
Market Size (Forecast)	USD 4.17 Billion
CAGR	17.60%
Major Market Players	Data provided in full report

A research report on the Pirfenidone market by Extent Research provides the vital information associated with the market growth during the forecast timeframe. The document also covers information such as historical, current, and future growth rate and finances in order to help other companies gain better knowledge about the Pirfenidone market. The report offers elaborative data that will provide insights of competitive market status and what the future holds. In addition to all this, the Pirfenidone market report encompasses market analysis data based on region, company profile, application, distribution channel, and others.

Data provided by Extent Research. Source: https://www.extentresearch.com/pirfenidone-market

The study report on global Pirfenidone market covers the regions that have the industry flourishing. Also, the market size, share, revenue, opportunities, challenges, and import/export analysis are accurately mentioned to get a clear picture about the future growth rate. The regions covered include North America, Europe, Asia Pacific, Latin America, Middle East & Africa. There are valuable insights of the market coupled with the strategic plans that undoubtedly will help the Pirfenidone business expand and penetrate further into the market.

The competitive players Genentech (Roche), Shionogi, GNI Group, Beijing Continent, Cipla, Lupin Ltd, Zydus Cadila, Glenmark Pharmaceuticals, Koye Pharmaceuticals, MSN Laboratories, Wockhardt, Incepta Pharmaceuticals, Unimed Unihealth, are well analyzed to provide advantages of the various business strategies, government policies, technological advancements, and new product launches on the Pirfenidone market. Like any other report, this report focuses on the industry sales, share, revenue, threats, and opportunities to expand in various regions across the globe. In the end, Pirfenidone market report delivers a conclusion that includes consumer preferences or needs, estimated market size, market analysis, and other factors likely to enhance the business overall.

Segmentation of the Global Pirfenidone Market:

By Product type

Tablet, Capsule, Other,

by Application

Mild Idiopathic Pulmonary Fibrosis, Moderate Idiopathic Pulmonary Fibrosis, Other,

Report provides answers for the following:

Which are the key market players in the Pirfenidone industry?
What the strategies followed by key players to combat this covid-19 event?
What is expected growth rate of the global Pirfenidone market during the forecast period?
What will be the estimated value of Pirfenidone market in the during the forecast period?
What are opportunities, challenges, and threats the market will face to survive?

Report Scope and Market Segmentation

ATTRIBUTES	Global Pirfenidone Market KEY MARKET INSIGHTS
Segments Covered	By Product Type: All Products Type Includes By Application: All Application Type Includes By End User: All End User Type Includes By Distribution Channel: All Distribution Channel Includes
Countries Covered	North America U.S., Canada, Mexico Europe Germany, United Kingdom, France, Italy, Spain, Nordic Countries, Benelux Union, Rest of Europe Asia-Pacific China, India, Japan, New Zealand, South Korea, Australia, Southeast Asia, Rest of Asia Pacific Latin America Brazil, Argentina, Rest of Latin America Middle East & Africa Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa
Key Market Players	Leading Tier 1 Corporations Prominent Regional Manufacturers Emerging Market Disruptors Technology Integrators & Suppliers *Complete vendor layout of 15+ major players provided in the final report.
Market Opportunities	Market Size and Growth: Quantifying the total addressable market (TAM) and projected growth rates to assess financial viability. Customer Segmentation: Identifying target audience behaviors, pain points, and specific unfulfilled demands. Competitive Landscape: Analyzing existing competitors' strengths, weaknesses, and market share to pinpoint gaps and opportunities. Industry Trends: Mapping technological, regulatory, and economic shifts that create favorable conditions for market entry. Risk Assessment: Evaluating barriers to entry and operational challenges alongside strategic roadmaps for mitigation.
Value Added Data Infosets	In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by our expert team also include in-depth expert analysis, geographically represented company-wise production and capacity, network layouts of distributors and partners, detailed and updated price trend analysis and deficit analysis of supply chain and demand.

Meet the Team

Julie

Author

Julie Jayne is a distinguished multidisciplinary strategist and the Head of Research at Extent Research, where she leverages over a decade of comprehensive experience in the global market intelligence industry. Backed by a robust academic foundation that includes a B.Sc. and an MBA, she perfectly...

Priya M

Reviewed By

With over 14 years of dedicated professional expertise in business-to-business (B2B) intelligence, Priya M stands as a distinguished leader in corporate strategy, revenue growth, and advanced data analysis. Her dynamic career is defined by a relentless focus on mitigating business risks and empowering corporate executives...

Learn more about Priya M

BASIC ATTRIBUTES \| KEY MARKET INSIGHTS
Report Title	Global Pirfenidone Market
Base Year	2025
Forecast Period	2025 - 2033
Market Size (Base)	USD 1.14 Billion
Projected Size	USD 4.17 Billion
CAGR	17.60%

                            1 Study Coverage
    1.1 Pirfenidone Product Introduction
    1.2 Market by Type
        1.2.1 Global Pirfenidone Market Size Growth Rate by Type, 2017 VS 2021 VS 2035
        1.2.2 Tablet
        1.2.3 Capsule
        1.2.4 Other
    1.3 Market by Application
        1.3.1 Global Pirfenidone Market Size Growth Rate by Application, 2017 VS 2021 VS 2035
        1.3.2 Mild Idiopathic Pulmonary Fibrosis
        1.3.3 Moderate Idiopathic Pulmonary Fibrosis
        1.3.4 Other
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Pirfenidone Sales Estimates and Forecasts 2017-2035
    2.2 Global Pirfenidone Revenue Estimates and Forecasts 2017-2035
    2.3 Global Pirfenidone Revenue by Region: 2017 VS 2021 VS 2035
    2.4 Global Pirfenidone Sales by Region
        2.4.1 Global Pirfenidone Sales by Region (2017-2022)
        2.4.2 Global Sales Pirfenidone by Region (2023-2035)
    2.5 Global Pirfenidone Revenue by Region
        2.5.1 Global Pirfenidone Revenue by Region (2017-2022)
        2.5.2 Global Pirfenidone Revenue by Region (2023-2035)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Pirfenidone Sales by Manufacturers
        3.1.1 Global Top Pirfenidone Manufacturers by Sales (2017-2022)
        3.1.2 Global Pirfenidone Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Pirfenidone in 2021
    3.2 Global Pirfenidone Revenue by Manufacturers
        3.2.1 Global Pirfenidone Revenue by Manufacturers (2017-2022)
        3.2.2 Global Pirfenidone Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Pirfenidone Revenue in 2021
    3.3 Global Pirfenidone Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Pirfenidone Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Pirfenidone Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Pirfenidone Sales by Type
        4.1.1 Global Pirfenidone Historical Sales by Type (2017-2022)
        4.1.2 Global Pirfenidone Forecasted Sales by Type (2023-2035)
        4.1.3 Global Pirfenidone Sales Market Share by Type (2017-2035)
    4.2 Global Pirfenidone Revenue by Type
        4.2.1 Global Pirfenidone Historical Revenue by Type (2017-2022)
        4.2.2 Global Pirfenidone Forecasted Revenue by Type (2023-2035)
        4.2.3 Global Pirfenidone Revenue Market Share by Type (2017-2035)
    4.3 Global Pirfenidone Price by Type
        4.3.1 Global Pirfenidone Price by Type (2017-2022)
        4.3.2 Global Pirfenidone Price Forecast by Type (2023-2035)
5 Market Size by Application
    5.1 Global Pirfenidone Sales by Application
        5.1.1 Global Pirfenidone Historical Sales by Application (2017-2022)
        5.1.2 Global Pirfenidone Forecasted Sales by Application (2023-2035)
        5.1.3 Global Pirfenidone Sales Market Share by Application (2017-2035)
    5.2 Global Pirfenidone Revenue by Application
        5.2.1 Global Pirfenidone Historical Revenue by Application (2017-2022)
        5.2.2 Global Pirfenidone Forecasted Revenue by Application (2023-2035)
        5.2.3 Global Pirfenidone Revenue Market Share by Application (2017-2035)
    5.3 Global Pirfenidone Price by Application
        5.3.1 Global Pirfenidone Price by Application (2017-2022)
        5.3.2 Global Pirfenidone Price Forecast by Application (2023-2035)
6 North America
    6.1 North America Pirfenidone Market Size by Type
        6.1.1 North America Pirfenidone Sales by Type (2017-2035)
        6.1.2 North America Pirfenidone Revenue by Type (2017-2035)
    6.2 North America Pirfenidone Market Size by Application
        6.2.1 North America Pirfenidone Sales by Application (2017-2035)
        6.2.2 North America Pirfenidone Revenue by Application (2017-2035)
    6.3 North America Pirfenidone Market Size by Country
        6.3.1 North America Pirfenidone Sales by Country (2017-2035)
        6.3.2 North America Pirfenidone Revenue by Country (2017-2035)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Pirfenidone Market Size by Type
        7.1.1 Europe Pirfenidone Sales by Type (2017-2035)
        7.1.2 Europe Pirfenidone Revenue by Type (2017-2035)
    7.2 Europe Pirfenidone Market Size by Application
        7.2.1 Europe Pirfenidone Sales by Application (2017-2035)
        7.2.2 Europe Pirfenidone Revenue by Application (2017-2035)
    7.3 Europe Pirfenidone Market Size by Country
        7.3.1 Europe Pirfenidone Sales by Country (2017-2035)
        7.3.2 Europe Pirfenidone Revenue by Country (2017-2035)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Pirfenidone Market Size by Type
        8.1.1 Asia Pacific Pirfenidone Sales by Type (2017-2035)
        8.1.2 Asia Pacific Pirfenidone Revenue by Type (2017-2035)
    8.2 Asia Pacific Pirfenidone Market Size by Application
        8.2.1 Asia Pacific Pirfenidone Sales by Application (2017-2035)
        8.2.2 Asia Pacific Pirfenidone Revenue by Application (2017-2035)
    8.3 Asia Pacific Pirfenidone Market Size by Region
        8.3.1 Asia Pacific Pirfenidone Sales by Region (2017-2035)
        8.3.2 Asia Pacific Pirfenidone Revenue by Region (2017-2035)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Pirfenidone Market Size by Type
        9.1.1 Latin America Pirfenidone Sales by Type (2017-2035)
        9.1.2 Latin America Pirfenidone Revenue by Type (2017-2035)
    9.2 Latin America Pirfenidone Market Size by Application
        9.2.1 Latin America Pirfenidone Sales by Application (2017-2035)
        9.2.2 Latin America Pirfenidone Revenue by Application (2017-2035)
    9.3 Latin America Pirfenidone Market Size by Country
        9.3.1 Latin America Pirfenidone Sales by Country (2017-2035)
        9.3.2 Latin America Pirfenidone Revenue by Country (2017-2035)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Pirfenidone Market Size by Type
        10.1.1 Middle East and Africa Pirfenidone Sales by Type (2017-2035)
        10.1.2 Middle East and Africa Pirfenidone Revenue by Type (2017-2035)
    10.2 Middle East and Africa Pirfenidone Market Size by Application
        10.2.1 Middle East and Africa Pirfenidone Sales by Application (2017-2035)
        10.2.2 Middle East and Africa Pirfenidone Revenue by Application (2017-2035)
    10.3 Middle East and Africa Pirfenidone Market Size by Country
        10.3.1 Middle East and Africa Pirfenidone Sales by Country (2017-2035)
        10.3.2 Middle East and Africa Pirfenidone Revenue by Country (2017-2035)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Genentech (Roche)
        11.1.1 Genentech (Roche) Corporation Information
        11.1.2 Genentech (Roche) Overview
        11.1.3 Genentech (Roche) Pirfenidone Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Genentech (Roche) Pirfenidone Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Genentech (Roche) Recent Developments
    11.2 Shionogi
        11.2.1 Shionogi Corporation Information
        11.2.2 Shionogi Overview
        11.2.3 Shionogi Pirfenidone Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Shionogi Pirfenidone Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Shionogi Recent Developments
    11.3 GNI Group
        11.3.1 GNI Group Corporation Information
        11.3.2 GNI Group Overview
        11.3.3 GNI Group Pirfenidone Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 GNI Group Pirfenidone Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 GNI Group Recent Developments
    11.4 Beijing Continent
        11.4.1 Beijing Continent Corporation Information
        11.4.2 Beijing Continent Overview
        11.4.3 Beijing Continent Pirfenidone Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Beijing Continent Pirfenidone Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Beijing Continent Recent Developments
    11.5 Cipla
        11.5.1 Cipla Corporation Information
        11.5.2 Cipla Overview
        11.5.3 Cipla Pirfenidone Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Cipla Pirfenidone Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Cipla Recent Developments
    11.6 Lupin Ltd
        11.6.1 Lupin Ltd Corporation Information
        11.6.2 Lupin Ltd Overview
        11.6.3 Lupin Ltd Pirfenidone Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Lupin Ltd Pirfenidone Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Lupin Ltd Recent Developments
    11.7 Zydus Cadila
        11.7.1 Zydus Cadila Corporation Information
        11.7.2 Zydus Cadila Overview
        11.7.3 Zydus Cadila Pirfenidone Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Zydus Cadila Pirfenidone Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Zydus Cadila Recent Developments
    11.8 Glenmark Pharmaceuticals
        11.8.1 Glenmark Pharmaceuticals Corporation Information
        11.8.2 Glenmark Pharmaceuticals Overview
        11.8.3 Glenmark Pharmaceuticals Pirfenidone Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Glenmark Pharmaceuticals Pirfenidone Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Glenmark Pharmaceuticals Recent Developments
    11.9 Koye Pharmaceuticals
        11.9.1 Koye Pharmaceuticals Corporation Information
        11.9.2 Koye Pharmaceuticals Overview
        11.9.3 Koye Pharmaceuticals Pirfenidone Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Koye Pharmaceuticals Pirfenidone Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Koye Pharmaceuticals Recent Developments
    11.10 MSN Laboratories
        11.10.1 MSN Laboratories Corporation Information
        11.10.2 MSN Laboratories Overview
        11.10.3 MSN Laboratories Pirfenidone Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 MSN Laboratories Pirfenidone Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 MSN Laboratories Recent Developments
    11.11 Wockhardt
        11.11.1 Wockhardt Corporation Information
        11.11.2 Wockhardt Overview
        11.11.3 Wockhardt Pirfenidone Sales, Price, Revenue and Gross Margin (2017-2022)
        11.11.4 Wockhardt Pirfenidone Product Model Numbers, Pictures, Descriptions and Specifications
        11.11.5 Wockhardt Recent Developments
    11.12 Incepta Pharmaceuticals
        11.12.1 Incepta Pharmaceuticals Corporation Information
        11.12.2 Incepta Pharmaceuticals Overview
        11.12.3 Incepta Pharmaceuticals Pirfenidone Sales, Price, Revenue and Gross Margin (2017-2022)
        11.12.4 Incepta Pharmaceuticals Pirfenidone Product Model Numbers, Pictures, Descriptions and Specifications
        11.12.5 Incepta Pharmaceuticals Recent Developments
    11.13 Unimed Unihealth
        11.13.1 Unimed Unihealth Corporation Information
        11.13.2 Unimed Unihealth Overview
        11.13.3 Unimed Unihealth Pirfenidone Sales, Price, Revenue and Gross Margin (2017-2022)
        11.13.4 Unimed Unihealth Pirfenidone Product Model Numbers, Pictures, Descriptions and Specifications
        11.13.5 Unimed Unihealth Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Pirfenidone Industry Chain Analysis
    12.2 Pirfenidone Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Pirfenidone Production Mode & Process
    12.4 Pirfenidone Sales and Marketing
        12.4.1 Pirfenidone Sales Channels
        12.4.2 Pirfenidone Distributors
    12.5 Pirfenidone Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Pirfenidone Industry Trends
    13.2 Pirfenidone Market Drivers
    13.3 Pirfenidone Market Challenges
    13.4 Pirfenidone Market Restraints
14 Key Findings in The Global Pirfenidone Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer                        

Research Methodology

Data collection and base year analysis are done using proprietary data collection modules with large sample sizes. The process includes obtaining market information through extensive secondary sources, paid databases, and verifying data via primary (industry expert) validation.

Our market models include Vendor Positioning Grids, Market Timeline Analysis, Company Market Share Analysis, and Top-Down/Bottom-Up forecasting models. To know more about the research methodology, drop an inquiry to speak to our industry experts.

Speak to Analyst

Global Pirfenidone Market